A Synergetic Screening Approach with Companion Effector for Combination Therapy: Application to Retinoblastoma

Jeni P. Mahida; Christophe Antczak; Daniel DeCarlo; Kathryn G. Champ; Jasmine H. Francis; Brian Marr; Arthur S. Polans; Daniel M. Albert; David H. Abramson; Hakim Djaballah

doi:10.1371/journal.pone.0059156

Loading metrics

Open Access

Peer-reviewed

Research Article

A Synergetic Screening Approach with Companion Effector for Combination Therapy: Application to Retinoblastoma

Jeni P. Mahida,

Affiliation HTS Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯
Christophe Antczak ,

* E-mail: antczakc@mskcc.org

Affiliation HTS Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯
Daniel DeCarlo,

Affiliation HTS Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯
Kathryn G. Champ,

Affiliation HTS Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯
Jasmine H. Francis,

Affiliation Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯
Brian Marr,

Affiliation Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯
Arthur S. Polans,

Affiliation Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States of America
⨯
Daniel M. Albert,

Affiliation Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States of America
⨯
David H. Abramson,

Affiliation Ophthalmic Oncology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯
Hakim Djaballah

Affiliation HTS Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America
⨯

A Synergetic Screening Approach with Companion Effector for Combination Therapy: Application to Retinoblastoma

Jeni P. Mahida,
Christophe Antczak,
Daniel DeCarlo,
Kathryn G. Champ,
Jasmine H. Francis,
Brian Marr,
Arthur S. Polans,
Daniel M. Albert,
David H. Abramson,
Hakim Djaballah

Published: March 19, 2013
https://doi.org/10.1371/journal.pone.0059156

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Library screening
Is the Subject Area "Library screening" applicable to this article?

Thanks for your feedback.
Microtubules
Is the Subject Area "Microtubules" applicable to this article?

Thanks for your feedback.
Retinoblastoma cells
Is the Subject Area "Retinoblastoma cells" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Skin tumors
Is the Subject Area "Skin tumors" applicable to this article?

Thanks for your feedback.